Evidence map›Paper›PMID 30225067›Full record

ArticleRoyal Society open science2018

Identification of 16,25-

Wenxue Wang, Haoran Yang, Ying Li, Zhongfei Zheng, Yongjun Liu, Haiyang Wang, Yanling Mu, Qingqiang Yao

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Royal Society open science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Wenxue WangSchool of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, Jinan 250200, Shandong, People's Republic of China.
Haoran YangSchool of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, Jinan 250200, Shandong, People's Republic of China.
Ying LiInstitute of Materia Medica, Shandong Academy of Medical Sciences, Jinan 250062, Shandong, People's Republic of China.
Zhongfei ZhengInstitute of Materia Medica, Shandong Academy of Medical Sciences, Jinan 250062, Shandong, People's Republic of China.
Yongjun LiuInstitute of Materia Medica, Shandong Academy of Medical Sciences, Jinan 250062, Shandong, People's Republic of China.
Haiyang WangInstitute of Materia Medica, Shandong Academy of Medical Sciences, Jinan 250062, Shandong, People's Republic of China.
Yanling MuInstitute of Materia Medica, Shandong Academy of Medical Sciences, Jinan 250062, Shandong, People's Republic of China.ORCID 0000-0002-4609-9363
Qingqiang YaoInstitute of Materia Medica, Shandong Academy of Medical Sciences, Jinan 250062, Shandong, People's Republic of China.
Shandong First Medical University · CNUniversity of Jinan · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Seven new cucurbitane glucosides, hemslepensides J-P (

Indexed as

anti-cancerCucurbitaceaecucurbitane triterpenoidHemsleya pengxianensis

Identifiers

PMID30225067
PMCPMC6124052
OpenAlexW2887190241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.